Streetbeat News

Analyst Ratings

SOL

Northland Capital Markets analyst Donovan Schafer downgraded Emeren Group (NYSE:SOL) from Outperform to Market Perform and reduced the price target from $6 to $3.2.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 2:47 pm

SHOT

Capybara Research issued a short report on Safety Shot, Inc., titled 'Safety Shot Exposed $SHOT,' alleging fraudulent activities and dubious claims about their alcohol detox drink. The report highlights red flags such as leadership ties to Stratton Oakmont, a history of financial troubles for founders Brian John and Richard Miller, and associations with known frauds. The report also criticizes the company's product claims and aggressive stock promotion, suggesting that the stock price is likely to fall and labeling the company as a potential OTC market failure. Capybara Research discloses a short position in $SHOT.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 2:45 pm

GBDC

Keefe, Bruyette & Woods analyst Ryan Lynch has maintained an Outperform rating on Golub Capital BDC (NASDAQ:GBDC) and increased the price target from $16.5 to $17, as reported on November 21, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 2:43 pm

FIHL

Keefe, Bruyette & Woods analyst Meyer Shields has maintained an Outperform rating on Fidelis Insurance Holdings (NYSE:FIHL) but reduced the price target from $18 to $17.5.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 2:41 pm

BIDU

Goldman Sachs analyst Lincoln Kong has maintained a Buy rating on Baidu (NASDAQ:BIDU) but has reduced the price target from $181 to $174.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 2:38 pm

MOR

Goldman Sachs analyst Rajan Sharma has maintained a Neutral rating on MorphoSys (NASDAQ:MOR) but has reduced the price target from $9.25 to $4.75.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 2:37 pm

WDC

Goldman Sachs analyst Toshiya Hari has maintained a Neutral rating on Western Digital (NASDAQ:WDC) and increased the price target from $31 to $48.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 2:35 pm

SYM

Goldman Sachs analyst Mark Delaney has maintained a Neutral rating on Symbotic (NASDAQ:SYM) and increased the price target from $36 to $40.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 2:33 pm

JWN

Goldman Sachs analyst Brooke Roach has maintained a Neutral rating on Nordstrom (NYSE:JWN) and reduced the price target from $18 to $16.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 2:32 pm

LFST

Goldman Sachs analyst Jamie Perse has maintained a Neutral rating on LifeStance Health Group (LFST) but has reduced the price target from $9 to $8.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 2:22 pm